PCC
GILD icon

Park Circle Company’s Gilead Sciences GILD Stock Holding History

Park Circle Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-400
Closed -$32K – 95
2016
Q3 		$32K Hold
400
– – 0.02% 84
2016
Q2 		$33K Buy
+400
New +$35.5K 0.02% 77

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Park Circle Company's GILD Position: Q4 2016 in Review

Park Circle Company sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 400 shares — an estimated $32K sold.

Park Circle Company first reported a position in GILD in Q2 2016 and held it in 2 quarters. The position peaked at $33K in Q2 2016. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Park Circle Company reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Park Circle Company sold 400 Gilead Sciences shares in Q4 2016, an estimated $32K.
  • Park Circle Company first reported a position in Gilead Sciences in Q2 2016 and held it in 2 quarters.
  • Park Circle Company's Gilead Sciences position peaked at $33K in Q2 2016.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Park Circle Company's 13F filing for Q4 2016, filed 9 Feb 2017.